Goldman Sachs’s Intercure INCR Stock Holding History
Bought
Maintained
Sold
Other funds holding INCR
AI
MCM
RWM
QC
Goldman Sachs's INCR Position: Q4 2025 in Review
Goldman Sachs sold out of Intercure (INCR) in Q4 2025, closing a stake of 1,262,726 shares — an estimated $2.07M sold.
Goldman Sachs first reported a position in INCR in Q3 2021 and held it in 3 quarters. The position peaked at $2.07M in Q3 2025. 19 funds tracked by Wall St. Rank hold INCR as of Q4 2025.
- Goldman Sachs reported no remaining Intercure position as of Q4 2025 after selling out during the quarter.
- Goldman Sachs sold 1,262,726 Intercure shares in Q4 2025, an estimated $2.07M.
- Goldman Sachs first reported a position in Intercure in Q3 2021 and held it in 3 quarters.
- Goldman Sachs's Intercure position peaked at $2.07M in Q3 2025.
- 19 funds tracked by Wall St. Rank held Intercure as of Q4 2025.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.